Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | SI | P14410 | 1/20 | 0.39 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | CSF1R | P07333 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26625969 | 0.87 | MGAM (0.41) | MGAMGAASIMGAM2ALOX15 | |
| SCHEMBL25288073 | 0.82 | — | — | |
| SCHEMBL30620779 | 0.82 | GAA (0.41) | MGAMGAASIMGAM2ALOX15 | |
| SCHEMBL31359625 | 0.67 | MGAM (0.46) | MGAMGAASIMGAM2ALOX15 | |
| SCHEMBL25779014 | 0.67 | MGAM (0.46) | MGAMGAASIMGAM2ALOX15 | |
| SCHEMBL31359626 | 0.67 | MGAM (0.46) | MGAMGAASIMGAM2ALOX15 | |
| SCHEMBL27843171 | 0.66 | MMP8 (0.49) | MGAMGAASIMGAM2LMNA | |
| SCHEMBL16840132 | 0.66 | PRMT1 (0.38) | — | |
| SCHEMBL8254860 | 0.65 | PRMT1 (0.38) | — | |
| SCHEMBL8253157 | 0.65 | PRMT1 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230202963-A1 | ESTERS AS FRAGRANCE COMPOUNDS | SYMRISE AG (DE) | 2023-06-29 | — | — | US | disclosed |
| US-20230202963-A1 | ESTERS AS FRAGRANCE COMPOUNDS | SYMRISE AG (DE) | 2023-06-29 | — | — | US | disclosed |
| US-20230202963-A1 | ESTERS AS FRAGRANCE COMPOUNDS | SYMRISE AG (DE) | 2023-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230202963-A1 | ESTERS AS FRAGRANCE COMPOUNDS | CUTA, TRPA1, FASN | MGAM 3672/4885GAA 3084/4885SI 958/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.